Physicians and the prescription of hormone replacement therapy in Spain

被引:13
作者
Bermejo, MJ
Pérez, IR
机构
[1] Escuela Andaluza Salud Publ, E-18080 Granada, Spain
[2] Hosp Univ Virgen Nieves, Dept Prevent Med, Granada, Spain
关键词
hormone replacement therapy; menopause; drug prescription; health care;
D O I
10.1016/j.healthpol.2004.10.001
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: The purpose of this study was to determine the frequency of hormone replacement therapy (HRT) prescription and identify women's sociodemographic and climacteric factors, as well as variables related to healthcare, associated with the treatment's prescription in women aged 45-65 years in the reference population of a primary healthcare centre in the city of Granada (Spain). Methods: A descriptive cross-sectional telephone survey was conducted in July 2002 with women aged 45-65 years from the reference population of a primary healthcare centre. The information was gathered using a semi-structured questionnaire specifically developed to gather information on the prescription of HRT. Results: 22.3% of the sample had ever been prescribed with HRT. Regarding compliance with the treatment, 44.2% of the women prescribed with this therapy took it partially, and 8.1% did not begin with the treatment. The variables independently associated with HRT prescription were having the menopause (OR = 2.81; IC 95%: 1.08-7.28), having psychological symptoms (OR = 2.77; IC 95%: 1.19-6.46), going to see the gynaecologist (OR = 4.41; IC 95%: 1.87-10.36), and the fact that the doctor worked in the private healthcare sector (OR = 3.55; IC 95%: 0.92-13.65). Conclusions: The frequency of HRT prescription in Spain is high, as well as the non-compliance rate. Reaching the menopause and going to the gynaecologist are determinant in HRT prescription. It would be desirable to use similar methodological approaches in studies of this controversial therapy, in order to obtain consensus on the real impact on the female population, particularly in view of the results of the latest clinical trials. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:58 / 65
页数:8
相关论文
共 37 条
[1]  
Avis N E, 2001, Climacteric, V4, P243, DOI 10.1080/713605090
[2]   Hormone replacement therapy in Norwegian women, 1996-1997 [J].
Bakken, K ;
Eggen, AE ;
Lund, E .
MATURITAS, 2001, 40 (02) :131-141
[3]  
Bulliyya G, 2001, J Indian Med Assoc, V99, P478
[4]   Correlates of hormone replacement therapy use in Italian women, 1992-1996 [J].
Chiaffarino, F ;
Parazzini, F ;
La Vecchia, C ;
Bianchi, MM ;
Benzi, G ;
Ricci, E ;
Chiantera, V .
MATURITAS, 1999, 33 (02) :107-115
[5]   Determinants of long-term hormone replacement therapy and reasons for early discontinuation [J].
Den Tonkelaar, I ;
Oddens, BJ .
OBSTETRICS AND GYNECOLOGY, 2000, 95 (04) :507-512
[6]   THE EVOLUTION OF CLINICAL POLICIES [J].
DIXON, AS .
MEDICAL CARE, 1990, 28 (03) :201-220
[7]   Hormone replacement therapy: changes in frequency and type of prescription by Dutch GPs during the last decade of the millennium [J].
Donker, GA ;
Spreeuwenberg, P ;
Bartelds, AIM ;
van der Velden, K ;
Foets, M .
FAMILY PRACTICE, 2000, 17 (06) :508-513
[8]   Noncardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [J].
Hulley, S ;
Furberg, C ;
Barrett-Connor, E ;
Cauley, J ;
Grady, D ;
Haskell, W ;
Knopp, R ;
Lowery, M ;
Satterfield, S ;
Schrott, H ;
Vittinghoff, E ;
Hunninghake, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01) :58-66
[9]   Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease [J].
Humphrey, LL ;
Chan, BKS ;
Sox, HC .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (04) :273-284
[10]  
*ICARUS STUD GROUP, 2000, CLIMACTERIC J INT ME, V3, P241